Literature DB >> 36224441

Investigation of molecular mechanisms underlying JAK/STAT signaling pathway in HPV-induced cervical carcinogenesis using 'omics' approach.

Kulbhushan Thakur1, Divya Janjua1, Gauri Shishodia2,3, Arun Chhokar1, Nikita Aggarwal1, Joni Yadav1, Tanya Tripathi1, Apoorva Chaudhary1, Anna Senrung1, Alok Chandra Bharti4,5.   

Abstract

The precise mechanism of action of Janus Kinases (JAK)/Signal Transducer and activator of Transcription (STAT) signaling in human papillomavirus (HPV)-associated cervical cancer (CaCx) is poorly defined. The present study dissected the underlying components of JAK/STAT signaling in HPV-positive cervical neoplasms. Whole transcriptome profile of CaCx cohort from TCGA database revealed elevated STAT3 and its impact on CaCx patients' survival. Using the RT2 Profiler PCR Array, we analyzed 84 genes of interest associated with JAK/STAT signaling in mRNA derived from HPV-negative and HPV-positive cervical lesions which revealed 21 differentially expressed genes (DEGs). Analyses of DEGs using the Database for Annotation, Visualization and Integrated Discovery tool indicated maximum genes enriched in immune response and negative regulation of apoptotic process. Protein-protein network analysis indicated IL4, STAT5A, STAT4, and JAK3 to be the key genes in the interaction network. Further, 7 key DEGs (IL4R, IRF1, EGFR, OAS1, PIAS1, STAT4, and STAT5A) were validated in TCGA cohort using R2 platform. These genes were differentially expressed among HPV-positive cervical tissues and their correlation with STAT3 was established. EGFR and IL4R showed a comparatively strong correlation with STAT3 that supports their involvement in pathogenesis of CaCx. Finally, the Kaplan-Meier analysis established the prognostic association of the key DEGs, in CaCx cohort. The STAT3 and associated key genes discovered from our study establish a strong pathogenic role of JAK/STAT3 pathway in HPV-mediated cervical carcinogenesis.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cervical cancer (CaCx); Differentially expressed genes (DEGs); Human papillomavirus (HPV); Janus Kinases (JAK)/Signal Transducer and activator of Transcription (STAT) pathway

Mesh:

Substances:

Year:  2022        PMID: 36224441     DOI: 10.1007/s12032-022-01854-1

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.738


  59 in total

1.  Epigenetics of human papillomaviruses.

Authors:  Eric Johannsen; Paul F Lambert
Journal:  Virology       Date:  2013-08-13       Impact factor: 3.616

2.  CCAAT/enhancer binding protein beta binds to and activates the P670 promoter of human papillomavirus type 16.

Authors:  Iwao Kukimoto; Takamasa Takeuchi; Tadahito Kanda
Journal:  Virology       Date:  2005-11-22       Impact factor: 3.616

3.  Control of HPV 18 DNA replication by cellular and viral transcription factors.

Authors:  C Demeret; M Le Moal; M Yaniv; F Thierry
Journal:  Nucleic Acids Res       Date:  1995-12-11       Impact factor: 16.971

Review 4.  Cellular control of human papillomavirus oncogene transcription.

Authors:  F Hoppe-Seyler; K Butz
Journal:  Mol Carcinog       Date:  1994-07       Impact factor: 4.784

5.  Human Papillomavirus awareness, knowledge and vaccine acceptance: a survey among 18-25 year old male and female vocational school students in Berlin, Germany.

Authors:  Susanne Blödt; Christine Holmberg; Jacqueline Müller-Nordhorn; Nina Rieckmann
Journal:  Eur J Public Health       Date:  2011-12-23       Impact factor: 3.367

6.  Variant upstream regulatory region sequences differentially regulate human papillomavirus type 16 DNA replication throughout the viral life cycle.

Authors:  Walter G Hubert
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

Review 7.  Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma.

Authors:  Françoise Thierry
Journal:  Virology       Date:  2008-12-07       Impact factor: 3.616

8.  Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA.

Authors:  Viviane Bechtold; Peter Beard; Kenneth Raj
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

Review 9.  The papillomavirus E2 proteins.

Authors:  Alison A McBride
Journal:  Virology       Date:  2013-07-10       Impact factor: 3.616

Review 10.  Epigenetic regulation of human papillomavirus transcription in the productive virus life cycle.

Authors:  Megan Burley; Sally Roberts; Joanna L Parish
Journal:  Semin Immunopathol       Date:  2020-01-09       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.